Rollins Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-2,717
| Closed | -$304K | – | 126 |
|
2021
Q4 | $304K | Buy |
+2,717
| New | +$304K | 0.09% | 89 |
|
2021
Q2 | $1.2M | Buy |
8,826
+939
| +12% | +$127K | 0.44% | 33 |
|
2021
Q1 | $1.07M | Sell |
7,887
-25
| -0.3% | -$3.39K | 0.46% | 30 |
|
2020
Q4 | $1.11M | Buy |
+7,912
| New | +$1.11M | 0.51% | 26 |
|